[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:intracranial-lesion":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":15,"states":16},"Intracranial Lesion",1,[7],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT07493447","Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures",[11],"Early Phase 1","RECRUITING","2026-08-26T02:18:38.077159Z","2026-07-05T03:45:20.252798Z",[],[]]